-
Cancer Drug Trial Provides Lessons for Future
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
-
Feinberg Investigators Lead AHA Heart Disease Research Initiative
Feinberg investigators have been selected to lead a $15 million American Heart Association research initiative studying the role of inflammation in heart disease.
-
Feinberg Classmates Reconnect and Reminisce at Alumni Weekend 2024
More than 450 alumni and guests returned to Feinberg on April 18, 19 and 20 to reconnect with former classmates, learn about the medical school’s latest developments and achievements, and reminisce about their medical school experiences.
-
Prospective Medical Students Visit Northwestern for Second Look
Feinberg recently hosted a “Second Look” event, providing 150 accepted students with an opportunity to learn more about the medical school’s campus, health equity and inclusion efforts, curriculum and community.
-
MRI Surveillance Significantly Reduces Breast Cancer Mortality
Women with breast cancer who carried the BRCA1 breast cancer mutation and who were enrolled in an MRI surveillance program saw an 80 percent reduction in breast cancer mortality compared to those who did not undergo MRI surveillance, according to findings published in JAMA Oncology.
-
Northwestern and CERN Step into Collaborative Leadership Role, Fostering Innovation in Open Science
Kristi Holmes, PhD, associate dean for knowledge management and strategy and director of Galter Health Sciences Library will co-lead the initiative focused on enhancing open-source scientific data.
-
Setting International Standards for Diagnosing Pediatric Sepsis
A large international team led by a Northwestern Medicine investigator has established new standardized diagnostic criteria for pediatric sepsis, according to two related studies published in JAMA.
-
Deploying Polygenic Risk Scores in Primary Care Settings
A multi-institutional team of investigators have developed a new framework for supporting healthcare providers in implementing polygenic risk score-based testing into primary care settings, according to a recent study published in Nature Medicine.
-
Trailblazing Biochemist Delivers Kimberly Prize Lecture
Influential biochemist Craig M. Crews, PhD, who pioneered the pharmaceutical field of targeted protein degradation, delivered the second Kimberly Prize in Biochemistry and Molecular Genetics Lecture to a full auditorium of Feinberg faculty, staff, fellows and students.
-
‘Polypills’ Can Help Patients Reduce Heart Disease Risk
Combining multiple heart disease drugs into a single “polypill” can lower bad cholesterol and blood pressure, boost medication adherence, and reduce the risk of cardiovascular disease and death, according to a meta-analysis of recent clinical trials published in Nature Medicine.
-
One in Four U.S. Adolescents Identify as Non-Heterosexual, Comparative Analysis Finds
A recent Northwestern Medicine comparative analysis of national survey results found that one in four U.S. adolescents in grades 9 through 12 reported their sexual identity as non-heterosexual, according to findings published in JAMA Pediatrics.
-
Uncovering the Culprits of Neurodegenerative Disorders
Recent studies from Feinberg scientists have uncovered new insights into these disorders, elucidating the mechanisms behind Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis, or ALS.
-
Developing Tools to Explore DNA Methylation
A Northwestern Medicine study has detailed the development of a machine learning model to predict DNA methylation status in cell-free DNA by its fragmentation patterns, according to findings published in Nature Communications.
-
Potential Therapeutic Target for Small Cell Lung Cancer Discovered
Northwestern Medicine investigators have discovered that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell lung cancer cells may decrease cancer cell differentiation and tumor growth, according to findings published in Nature Communications.
-
2024 Population Health Forum Rallies Public Health Workers and Allies From Across Illinois
Health experts from across the state visited Northwestern for the fifth annual Population Health Forum, focusing on maternal health, racial disparities, endemic violence and other pressing public health issues.
-
Novel Mechanism Supports Antitumor Response and T-cell Survival
A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of Clinical Investigation.
-
Probing Deeper to Understand Protein Expression in Neurons
Northwestern Medicine investigators have developed a method to measure protein expression in an individual neuron type, according to a study published in Molecular Psychiatry.
-
Novel Biological Mechanism Discovered That Could Lead to New Treatments for Neurological Disorders, Cancers
The lab of Yongchao C. Ma, PhD, has discovered a fundamental biological mechanism that could lead to new treatments for neurological diseases, such as spinal muscular atrophy (SMA) and autism, as well as different cancers.
-
Eminent Epidemiologist Mercedes Carnethon Named Chair of Preventive Medicine
Mercedes Carnethon, PhD, vice chair and Mary Harris Thompson Professor of Preventive Medicine and co-chair of the Appointments, Promotions, and Tenure Committee at Northwestern University Feinberg School of Medicine, has been named chair of the Department of Preventive Medicine, effective September 1.
-
Tracking the Evolution of COVID-19
Scientists have developed a machine-learning approach to track the evolution of the COVID-19 virus and potentially others, according to a study published in the Proceedings of the National Academy of Sciences.
